Spain's pharma spend grew 6.9% in 2008

9 March 2009

The Spanish drug industry body, Farmaindustria, reports that, during  2008, each citizen was prescribed, on average, 19.3 prescriptions,  which represents 3.3% growth compared to 2007. In the 2005-2008 period,  the average prescription consumption per capita had risen 11.2%. Last  year, the increase of the average price of prescriptions was lower than  the Consumer Price Index. Drug spending in 2008 increased 6.9% to 11.96  billion euros ($15.24 billion), due to the larger demand for  prescriptions (80%) deriving from an increasing population and a  greater number of elderly patients.

Over January 2005 and December 2008, Spain's general economy CPI grew  13.5%, while the average cost per Rx only rose 2.9% and the medicines  subclass index included in the general CPI dropped 19%. This is  attributed to across-the-board price cuts ordered by the government  which came into force in March in 2005 and 2006 (4.2% and 2%,  respectively) and the drop in the average price of Rxs since the new  Reference Price System came into effect in 2007, later revised in 2008.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK









Company Spotlight